Myron Kaplan - Nov 16, 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Myron Kaplan
Stock symbol
CRMD
Transactions as of
Nov 16, 2021
Transactions value $
$51,400
Form type
4
Date filed
11/19/2021, 03:45 PM
Previous filing
May 19, 2021
Next filing
Dec 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Purchase $51.4K +10K +6.06% $5.14 175K Nov 16, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRMD Stock Option (Right to Buy Common Stock) 30K Nov 16, 2021 Common Stock 30K $8.32 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 15K Nov 16, 2021 Common Stock 15K $5.63 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K Nov 16, 2021 Common Stock 15K $8.30 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 8K Nov 16, 2021 Common Stock 8K $2.85 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8K Nov 16, 2021 Common Stock 8K $11.20 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 10K Nov 16, 2021 Common Stock 10K $21.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F2 These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F3 These options were granted on 01/10/2019. These options are fully vested.
F4 These options were granted on 02/16/2018. These options are fully vested.
F5 These options were granted on 02/21/2017. These options are fully vested.
F6 These options were granted on 4/28/2016. These options are fully vested.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.